Quantitative prediction of bone mineral density by using bone turnover markers in response to antiresorptive agents in postmenopausal osteoporosis: A model‐based meta‐analysis-Reference-Cited by-同舟云学术

Quantitative prediction of bone mineral density by using bone turnover markers in response to antiresorptive agents in postmenopausal osteoporosis: A model‐based meta‐analysis

Published:2020-08-05 Issue:3 Volume:87 Page:1175-1186
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Wu Junyi¹²^ORCID,Wang Chen¹²³^ORCID,Li Guo‐Fu¹⁴^ORCID,Tang En‐Tzu⁵,Zheng Qingshan¹

Affiliation:

1. Center for Drug Clinical Research Shanghai University of Traditional Chinese Medicine Shanghai China

2. Clinical Pharmacology, Amgen Asia R&D Center Shanghai China

3. Clinical Pharmacology, China R&D and Medical Affairs Janssen Research & Development Shanghai China

4. Subei People's Hospital Yangzhou University Yangzhou Jiangsu China

5. Biostatistics, Amgen Asia R&D Center Shanghai China

Funder

Ministry of Science and Technology of the People's Republic of China

Science and Technology Commission of Shanghai Municipality

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14487

Reference47 articles.

1. Osteoporosis Prevention, Diagnosis, and Therapy

2. Trends in Fracture Incidence: A Population-Based Study Over 20 Years

3. Lifetime Risks of Hip, Colles', or Vertebral Fracture and Coronary Heart Disease Among White Postmenopausal Women

4. Perspective how many women have osteoporosis?

5. Epidemiology and outcomes of osteoporotic fractures

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TC and LDL-C are negatively correlated with bone mineral density in patients with osteoporosis;American Journal of Translational Research;2024

2. Optimization of the dosage regimen of zoledronic acid with a kinetic-pharmacodynamic model and exposure-response analysis;Frontiers in Pharmacology;2023-09-27

3. Resveratrol‐Induced Suppression of C‐type Natriuretic Peptide Associates With Increased Vertebral Bone Density in Postmenopausal Women;JBMR Plus;2023-03

4. Applications of Model-Based Meta-Analysis in Drug Development;Pharmaceutical Research;2022-02-16